NUK - logo
E-viri
Recenzirano Odprti dostop
  • Clinico-demographic profile...
    Mohan, Anant; Tiwari, Pawan; Bhatnagar, Sushma; Patel, Ankit; Maurya, Abhishek; Dar, Lalit; Pahuja, Sourabh; Garg, Rakesh; Gupta, Nishkarsh; Sahoo, Biswajeet; Gupta, Ritu; Meena, Ved; Vig, Saurabh; Pandit, Anuja; Mittal, Saurabh; Madan, Karan; Hadda, Vijay; Dwivedi, Tanima; Choudhary, Aashish; Brijwal, Megha; Soneja, Manish; Guleria, Randeep; Ratre, Brajesh; Kumar, Balbir; Bhopale, Shweta; Panda, Smriti; Singh, Angel; Singh, Sheetal; Wundavalli, Laxmitej

    Indian journal of medical research (New Delhi, India : 1994), 01/2020, Letnik: 152, Številka: 1
    Journal Article

    Background & objectives: In December 2019, a novel coronavirus (SARS-CoV-2) emerged in China and rapidly spread globally including India. The characteristic clinical observations and outcomes of this disease (COVID-19) have been reported from different countries. The present study was aimed to describe the clinico-demographic characteristics and in-hospital outcomes of a group of COVID-19 patients in north India. Methods: This was a prospective, single-centre collection of data regarding epidemiological, demographic, clinical and laboratory parameters, management and outcome of COVID-19 patients admitted in a tertiary care facility in north India. Patient outcomes were recorded as death, discharge and still admitted. Results: Data of 144 patients with COVID-19 were recorded and analyzed. The mean age of the patients was 40.1±13.1 yr, with 93.1 per cent males, and included 10 (6.9%) foreign nationals. Domestic travel to or from affected States (77.1%) and close contact with COVID-19 patients in congregations (82.6%) constituted the most commonly documented exposure. Nine (6.3%) patients were smokers, with a median smoking index of 200. Comorbidities were present in 23 (15.9%) patients, of which diabetes mellitus (n=16; 11.1%) was the most common. A significant proportion of patients had no symptoms (n=64; 44.4%); among the symptomatic, cough (34.7%) was the most common symptom followed by fever (17.4%) and nasal symptoms (2.15%). Majority of the patients were managed with supportive treatment with hydroxychloroquine and azithromycin given on a case-to-case basis. Only five (3.5%) patients required oxygen supplementation, four (2.8%) patients had severe disease requiring intensive care, one required mechanical ventilation and mortality occurred in two (1.4%) patients. The time to reverse transcription-polymerase chain reaction (RT-PCR) negativity was 16-18 days. Interpretation & conclusions: In this single-centre study of 144 hospitalized patients with confirmed COVID-19 in north India, the characteristic findings included younger age, high proportion of asymptomatic patients, long time to PCR negativity and low need for intensive care unit care.